What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis

Por Shaheen, N J, Inadomi, J M, Overholt, B F, Sharma, P
Publicado em 2004

Classification of functional dyspepsia based on concomitant bowel symptoms

Por Matsuzaki, J., Suzuki, H., Asakura, K., Fukushima, Y., Inadomi, J. M., Takebayashi, T., Hibi, T.
Publicado em 2012

THE IMPACT OF UNCERTAINTY IN BARRETT’S ESOPHAGUS PROGRESSION RATES ON HYPOTHETICAL SCREENING AND TREATMENT DECISIONS

Por Kroep, S., Lansdorp-Vogelaar, I., van der Steen, A., Inadomi, J.M., van Ballegooijen, M.
Publicado no Med Decis Making (2014)

Ascites improves upon serum sodium and MELD for predicting mortality in patients with advanced liver disease

Por SOMSOUK, M., GUY, J., BIGGINS, S.W., VITTINGHOFF, E., KOHN, M.A., INADOMI, J.M.
Publicado em 2009

AN ACCURATE CANCER INCIDENCE IN BARRETT’S ESOPHAGUS: A BEST ESTIMATE USING PUBLISHED DATA AND MODELING

Por Kroep, S., Lansdorp-Vogelaar, I., Rubenstein, J.H., de Koning, H.J., Meester, R., Inadomi, J.M., van Ballegooijen, M.
Publicado no Gastroenterology (2015)